PTH treatment also significantly decreased expression of CGRP and PGP9.5 within the DRG of both aged and LSI mouse models, underscoring the potential of PTH treatment in addressing the neuropathic components of LBP during spinal degeneration. This evidence concerns the gene UCHL1 and Low back pain.